위조 의약품 검출 장치 시장 예측(2025-2030년)

The Global Counterfeit Drug Detection Device Market is expected to grow from USD 1.742 billion in 2025 to USD 2.293 billion in 2030, at a CAGR of 5.65%.

Public Health Risks from Counterfeit Drugs

Counterfeit drugs pose a severe threat to global public health, contributing to illnesses and deaths, particularly in low- and middle-income countries. The World Health Organization estimates that counterfeit drugs account for approximately 10% of the global pharmaceutical market, with some regions exceeding 30%. In contrast, stringent regulatory systems in countries like Australia, Canada, and many EU nations limit counterfeit prevalence to less than 1%. The rise of e-commerce, with around 50% of counterfeit drugs sold through illegal websites with hidden addresses, exacerbates the issue. This growing threat, combined with a lack of awareness in vulnerable populations, drives demand for advanced detection devices to ensure drug authenticity and protect patient safety.

Regulatory and Industry Initiatives

Stringent regulations and heightened awareness among governments and healthcare organizations are fueling market growth. In 2023, the U.S. Food and Drug Administration seized over $4 billion worth of counterfeit pharmaceuticals, highlighting the need for robust detection solutions. Globally, regulatory bodies are enforcing stricter quality control standards, encouraging the adoption of advanced technologies to combat counterfeit drug trafficking. Pharmaceutical companies also face significant financial losses and reputational risks from counterfeit drugs, prompting increased investment in detection devices to safeguard supply chains.

Technological Advancements

Spectroscopy and Portable Devices

Technological innovations are at the forefront of market growth, with spectroscopy-based devices leading the charge. In March 2023, InVita Healthcare Technologies launched Pharma Defense, a pioneering solution focused on counterfeit drug detection, enhancing rapid on-site verification. Thermo Fisher Scientific's portable XRF Analyzer, NIR, and Raman Spectrometers enable on-site identification and quantification of pharmaceutical ingredients within 30 seconds, adhering to current good manufacturing practices and 21 CFR Part 11 standards. These devices provide fast, non-destructive analysis, minimizing reliance on time-consuming laboratory tests and ensuring high-quality verification to combat counterfeit drugs.

AI and Advanced Imaging

The integration of artificial intelligence (AI) and advanced imaging techniques is transforming counterfeit detection. In December 2023, Nynomic AG acquired Art Photonics GmbH, enhancing its fiber optic-based detection capabilities. AI-powered solutions, such as Stratio, Inc.'s imaging technology launched in December 2021 with support from South Korea's National IT Industry Promotion Agency, improve accuracy at border checkpoints. Additionally, Spectral Engines' NIRONE(R) Scanner, introduced in 2023, combines NIR technology with cloud connectivity and advanced algorithms, offering a turnkey solution for material analysis and fake drug detection.

RFID and Blockchain

Radio-frequency identification (RFID) and blockchain technologies are gaining traction for supply chain transparency. In 2024, the pharmaceutical industry increasingly adopted RFID to track falsified drugs, driven by regulatory mandates for QR codes and RFID tags on active pharmaceutical ingredients. Cloud-based blockchain frameworks, utilizing Hyperledger Fabric, enable secure, transparent tracking of pharmaceutical products, reducing counterfeit risks through serialized packaging and smart contracts.

Market Segmentation Analysis

Spectroscopy Segment

The spectroscopy segment, including Raman and near-infrared (NIR) technologies, held a significant market share in 2024, valued at USD 0.96 billion. Its non-destructive nature and rapid results make it ideal for on-site verification in pharmacies, border controls, and manufacturing facilities. The segment's growth is driven by demand for portable, user-friendly devices.

Portable Devices

Portable counterfeit detection devices, such as handheld scanners, are gaining popularity due to their flexibility and ease of use in field settings. These devices, including Thermo Fisher's TruScan Raman and microPHAZIR RX NIR analyzers, support rapid screening, enhancing accessibility and adoption across diverse end-users, including regulatory authorities and distributors.

Regional Insights

North America dominates the market, holding a 34.2% revenue share projected by 2037, driven by stringent regulations, advanced healthcare infrastructure, and high counterfeit drug awareness. The region's market was valued at USD 1.0 billion in 2024. The Asia-Pacific region is the fastest-growing, fueled by rising counterfeit drug prevalence, government initiatives, and local manufacturing of detection devices. China, with a 22% increase in fake drugs reported in 2023, is prioritizing advanced detection technologies. Europe follows, with a market size of USD 0.7 billion in 2024, supported by robust regulatory frameworks.

Market Challenges

High costs of advanced detection devices and limited awareness in developing regions pose challenges. Additionally, the sophistication of counterfeit drugs requires continuous technological upgrades, straining R&D budgets. Regulatory gaps in emerging markets further complicate enforcement efforts.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Modality

• Portable Devices
• Hand-Held Devices
• Bench-Top Devices

By Product Type

• RFID Analyzer
• Scanning and Imaging Systems
• Chromatographs
• Spectrometers
• Spectroscopes

By Technology

• Infrared and Near-Infrared Spectroscopy
• Microfluidic (Benchtop and Handheld Devices)
• Rapid Chemical Testing
• Raman Spectroscopy
• RFID Technology
• Other

By End User

• Pharmaceutical Companies
• Drug Testing Laboratories
• Research Organizations

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Others
• Middle East and Africa
• UAE
• Israel
• Saudi Arabia
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY MODALITY

• 5.1. Introduction
• 5.2. Portable Devices
• 5.3. Hand-Held Devices
• 5.4. Bench-Top Devices

6. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY PRODUCT TYPE

• 6.1. Introduction
• 6.2. RFID Analyzer
• 6.3. Scanning and Imaging Systems
• 6.4. Chromatographs
• 6.5. Spectrometers
• 6.6. Spectroscopes

7. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY TECHNOLOGY

• 7.1. Introduction
• 7.2. Infrared and Near-Infrared Spectroscopy
• 7.3. Microfluidic (Benchtop and Handheld Devices)
• 7.4. Rapid Chemical Testing
• 7.5. Raman Spectroscopy
• 7.6. RFID Technology
• 7.7. Other

8. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY END-USER

• 8.1. Introduction
• 8.2. Pharmaceutical Companies
• 8.3. Drug Testing Laboratories
• 8.4. Research Organizations

9. COUNTERFEIT DRUG DETECTION DEVICE MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Italy
  • 9.4.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. Taiwan
  • 9.6.5. Thailand
  • 9.6.6. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Bayer AG
• 11.2.Thermo Fisher Scientific Inc.
• 11.3.Spectral Engines Oy
• 11.4.GAO Group
• 11.5.Systech International
• 11.6.Advanced Systems Development, Inc.
• 11.7.B&W Tek
• 11.8.Centice Corporation
• 11.9.Consumer Physics
• 11.10.Global Pharma HealthCare Ltd.

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key benefits for the stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations